Member of the
Biocidal Products Committee (BPC)
Add your photo
1. Name (FAMILY NAME, First Name ) here!
Ms. / Mr
2. Appointed by (MS/MSC):
3. Nationality:
4. Education:
5. Relevant Employment
Present:
Relevant previous employment:
6. Relevant fields of in-depth expertise:
Area of expertise Description
7. Membership of relevant professional bodies:
8. Other Relevant Information:
ECHA DECLARATION OF INTEREST
There is a conflict of interest where the impartiality and objectivity of a decision, opinion
or recommendation of the Agency and/or its bodies, is or might in the public perception be
compromised by an interest held by, or entrusted to, an individual working for the Agency.
Please note that having an interest does not necessarily mean having a conflict of interest.
In particular, high quality of (scientific) expertise is by nature based on prior experience.
Declaring an interest does therefore not automatically disqualify you or limit your
participation in the activities of the European Chemicals Agency.
On the other hand it should be emphasised that this declaration of interest form does not
contain an exhaustive list of potential interests and that all other elements that might
jeopardise your independence when working with the Agency should thus also be
indicated. Your answers will then be reviewed and dealt with in accordance with the ECHA
Procedure for Prevention and Management of potential Conflicts of Interest.
Declaration of Commitment
I hereby declare that I shall make all reasonable efforts to fulfil my duties related to the
work of the European Chemicals Agency.
Declaration of Interests
First Name:
Last name:
Position in ECHA:
hereby declares to have the following interests:
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 1 of 6
I. Employment, consultancy, legal representation or advice
Within the past 5 years, were you employed or have you had any other professional
relationship with a commercial entity1 or other organisation2 with an interest in the
regulatory field of activity of ECHA?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or
commercial
entity
II. Membership of Governing Body, Scientific Advisory Body or
equivalent structure
Within the past 5 years, have you participated in the internal decision-making of a
commercial entity or other organisation with an interest in the regulatory field of activity
of ECHA (e.g. board membership, directorship) or have you participated in the works of a
Scientific Advisory Body with voting rights on the outputs of that entity?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or
commercial
entity
1
This includes any commercial business, consultancy, research institution or other enterprise whose funding is
significantly derived from commercial sources. It also includes independent own commercial businesses, law
offices, consultancies or similar.
2
An ‘organisation’ includes governmental, international or non-profit organisations, as well as interest groups.
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 2 of 6
III. Other membership or affiliation
Within the past 5 years, have you had any membership or affiliation other than the above
that can be perceived as creating a potential conflict of interest?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or
commercial
entity
IV. Research funding
Within the past 5 years, have you or the research entity to which you belong received any
support from a commercial entity or other organisation with an interest in the regulatory
field of activity of ECHA, including grants, rents, sponsorships, fellowships, non-monetary
support?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or
commercial
entity
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 3 of 6
V. Investments
Do you have current investments in a commercial entity with an interest in the regulatory
field of activity of ECHA, including holding of stocks and shares, stock options, equity,
bonds, partnership interest in the capital of such undertaking, one of its subsidiaries or a
company in the capital of which it has a holding and which amounts to more than 10,000
EUR per commercial entity or entitling you to a voting right of 5% or more in such
commercial entity?3
No
Yes, and more in particular:
Investment Name of organisation or commercial
entity
VI. Intellectual Property
Do you have any intellectual property rights (e.g. patent, trademark, copyright or
proprietary know-how) in the regulatory field of activity of ECHA that might create a
potential conflict of interest?
No
Yes, and more in particular:
Intellectual Property Name of Description
organisation or
commercial
entity
3
You may exclude financial interests held through an investment fund, pension fund and/or interests in non-
nominal unit trusts or similar arrangements, provided that these investments are broadly diversified and you
have no influence on their financial management.
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 4 of 6
VII. Public statements and positions
Within the past 5 years, have you provided any expert opinion or testimony in the
regulatory field of activity of ECHA for a commercial entity or other organisation as part of
a regulatory, legislative or judicial process? Have you held an office or other position, paid
or unpaid, where you represented interests or defended an opinion in the regulatory field
of activity of ECHA?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or
commercial
entity
VIII. Other relevant information
Are there any other elements that could be seen as jeopardising your independence when
working for the Agency?
No
Yes, and more in particular:
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 5 of 6
IX. Interests held by close family members4
Do any of your close family members hold any current interests in the regulatory field of
activity of the Agency (as specified above in the sections I.-VIII.)?
No
Yes, and more in particular:
Function/Activity Name of Description
organisation or
commercial entity
I wish to have any reference to interests held by close family members removed if this
declaration is to be made public on the ECHA website. 5
I hereby declare that I have read both the ECHA Procedure on Prevention and
Management of potential Conflicts of Interest and the related ECHA Guidance
document and that the above Declaration of Interest is at my best knowledge
complete. I understand that for all members of the ECHA bodies, the Executive Director
and the other ECHA management staff (Directors and Heads of Unit), as well as for the
chairpersons of the ECHA Committees this declaration will be published on the ECHA
website.
Please note that the European Chemicals Agency will ensure on its part that your personal
data hereby submitted is processed as required by Regulation (EC) No 45/2001 on the
protection of individuals with regard to the processing of personal data by the Community
institutions and bodies and on the free movement of such data. The data is necessary for
the purpose of implementing the Agency’s Procedure for Prevention and Management of
potential Conflicts of Interest and will be retained for a time period of 7 years. You have
the right to access and rectify that data. Under certain conditions, a right to erasure,
restriction, objection and/or data portability also applies. To exercise these rights, please
contact the relevant secretariat. You can contact the Agency’s Data Protection Officer for
any questions or complaints with regard to the processing of your personal data. In case
you do not receive a satisfactory outcome, you can have recourse to the European Data
Protection Supervisor.
Date:
4
For this purpose, ‘close family members’ are considered to be the persons forming a household with the
person making this declaration (spouse, partner, and/or dependent children). For privacy reasons neither the
relationship nor the name is to be included. Only current interests held by close family members are of relevance
and not past interests.
5
As full transparency is one of the general principles of this Procedure, this option should only be used in case
the consent of the individual concerned has not been obtained, when he/she has objected to the disclosure on
compelling legitimate grounds or if there is reason to believe that the legitimate interests of the individual
involved might be prejudiced by the disclosure (see also Regulation (EC) No 45/2001 on the protection of
personal data).
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 6 of 6
DECLARATION OF CONFIDENTIALITY OF ECHA BODIES1
I hereby declare that I shall undertake to exercise the greatest discretion with regard to all
facts and information coming to my knowledge in the course of or in connection with the
performance of my duties related to the work of the European Chemicals Agency. I shall not
disclose to any persons any information acquired as a result of such work unless otherwise
stipulated in European Union or national law or already publicly available. The above is
without prejudice to the sharing of documents with persons assisting me in the discharge
of my duties related to the work of the European Chemicals Agency. I shall take all necessary
measures to ensure that the persons to whom I provide access to information respect the
same obligations that I am subject to. I accept without reservation that I continue to be
bound by this obligation also after these duties have ceased.
If I have been granted such access, I also hereby confirm having read, understood and
that I commit to follow the rules2 regarding access to confidential information from S-
CIRCABC Interest Groups.
Name: Click here to enter text.
Position/Affiliation: Click here to enter text.
Place: Click here to enter text. Date: Click here to enter a date.
1
Management Board, Forum, Committee and Expert Groups Members, their advisers, invited experts and
observers, working groups, coordination groups, CIRCABC interest groups etc.
2
S-CIRCABC rules
FOR-0108.02
Uncontrolled copy once printed. Ensure that the right version is in use. Page 1 of 1
Doc: ED/28/2014 1(11)
Public
Helsinki, 4 April 2014
Guidance for filing in the Declaration of Interest
(Decision by the Executive Director)
Owner: Bo Balduyck Distribution:
Validity: Indefinite Executive Director
Revision: / Quality Manager
Classification: Public All Directors
All Heads of Unit
All Unit secretaries
ECHAnet
ECHA website
Doc: ED/28/2014 2(11)
Public
AS THE EXECUTIVE DIRECTOR OF THE EUROPEAN CHEMICALS AGENCY
I HAVE DECIDED THE FOLLOWING:
1. The attached Guidance for filling in the Declaration of Interest is adopted.
2. This decision shall apply as of the date of signature and shall replace decision
ED/67/2011 with the same title.
Done at Helsinki, 4 April 2014
[signed original available at the Executive Office]
Geert Dancet
Executive Director
Doc: ED/28/2014 3(11)
Public
GUIDANCE FOR FILLING IN THE
DECLARATION OF INTEREST
1. INTRODUCTION AND LEGAL BASIS
Based on the REACH Regulation (and, in particular, Articles 87 & 88), the Biocidal Products
Regulation and the Staff Regulations, all individuals working with the Agency should declare
all interests which could be considered to be prejudicial to their independence, either via an
annual declaration of interest or via a specific declaration at the start of a meeting or in
connection to a specific dossier.
All annual declarations will be made based on the form annexed to the Procedure for
Prevention and Management of potential Conflicts of Interests (MB/07/2014 final), and
entered in a register held by the Agency. The annual declarations of the members of the
Management Board, the Committees and the Forum, the members of the Board of Appeal,
the ECHA management staff (Executive Director, Directors and Heads of Unit) and of the
chairpersons of the ECHA Committees will be made publicly available via publication on the
Agency’s website.
Declarations of interest will be monitored and assessed in order to identify and avoid any
potential conflicts and agree on appropriate actions, if needed.
2. WHO SHOULD DECLARE?
All members, their advisors, and invited experts, of the ECHA Management Board, the ECHA
Committees and the Forum for Exchange of Information on Enforcement (hereinafter, ‘the
Forum’) are bound by the rules on conflicts of interest and must at each meeting of the
relevant Board, Committee, Forum or working group declare any interests which could be
considered to be prejudicial to their independence with respect to any points on the agenda.
Anyone declaring such interests shall not participate in any voting on the relevant agenda
point. Besides that, the members of those ECHA bodies are requested to make an annual
declaration of interest in writing.
Once appointed as a rapporteur or co-rapporteur, any Committee member is, in addition,
requested to make the declarations referred to in Article 87(1) of the REACH Regulation.
These declarations are, as a rule, signed in the context of the signature of the written
contract between ECHA and the individual concerned, referred to in Article 87(3) of the
REACH Regulation. A specific form is used for these declarations of absence of conflicting
interests, but the guidance laid down in this document might be useful for that purpose as
well.
All members of the Board of Appeal (regardless whether they are permanent, alternate or
additional members) shall annually submit a declaration of interest. Additionally, when
called up to work on a specific case, all such members shall make a case-specific no-interest
declaration.
All staff members of the Agency are also bound by the rules on conflicts of interest. This
shall include all statutory staff of the Agency, including all seconded officials, temporary
agents, contract agents and seconded national experts. This declaration will be renewed
annually. In addition, staff members must declare any potential ad hoc conflicts of interest
to the relevant process owner or to their immediate superior. While not formally being staff
members of the Agencyinterim staff and staff of external service providers and consultants
shall be bound by the stipulations of the contract that applies to them, including the
Doc: ED/28/2014 4(11)
Public
confidentiality and conflict of interest provisions foreseen in them. In some cases such
external staff may be requested to also sign a declaration of interest (using the same form),
with a focus on the specific tasks assigned to them.
For networks and expert groups working under the authority of the Agency as advisory
bodies, the risk of conflicting interests affecting the formal work of the Agency is minimal.
However, where necessary, members of such networks and expert groups may be
requested to declare conflicting interests at the start of a meeting and/or through annual
declarations of interest.
3. WHEN TO DECLARE?
Initial declaration: Upon appointment as a member of the Management Board, the Biocidal
Products Committee, the Member State Committee, or the Forum, or after signing an
employment contract as an ECHA staff member, each individual is required to fill in a
declaration of interest form.
In line with Article 11 of the Staff Regulations also all candidates that may be offered a
position in the Agency are requested to make a written declaration of interest in order for
the Appointing Authority to be able to assess, before recruitment, any potential conflicts of
interest in relation to the specific position that may be offered.
Similarly, candidates for the position of Executive Director or Accounting Officer and all
candidates for appointment as members of an ECHA body for which the Management Board
is the Appointing Authority (i.e. the Board of Appeal, the Risk Assessment Committee and
the Committee for Socio-economic Analysis) shall be requested to complete a declaration
following their placement on the list of candidates by the Commission or the nomination by
their respective Member State. This should allow the Management Board to analyse the
declarations made, in order to take an informed decision on each appointment.
Appointment as a rapporteur: A Committee/Forum member should not accept an
appointment as a rapporteur or co-rapporteur if they indicate any interests that might be
prejudicial to the independent consideration of a given case. For each case, the rapporteurs
and co-rapporteurs must make a declaration of absence of conflicts of interest in writing.
The declarations will normally be signed in the context of the signature of the written
contract between ECHA and the individual concerned, referred to in Article 87(3) of the
REACH Regulation.
Update of an initial declaration: Declarations must be updated annually or without delay
once relevant changes have occurred.
Spontaneous/specific declarations: At each meeting, members, their advisors, and invited
experts of the Management Board, the Committees and the Forum or its working groups,
must declare any interests that could be considered to be prejudicial to their independence
with respect to any points on the agenda. Anyone declaring such interests shall not
participate in any voting on the relevant agenda point. The spontaneous declarations will be
recorded in the minutes of the meeting. The same is true for the members of the Board of
Appeal who will be requested to make a case-specific no-interest declaration before starting
to work on an appeal case.
If, at any time in the course of their duties, a staff member becomes aware of any potential
or likely conflict of interest, they must immediately inform the relevant process owner who
will determine any appropriate action. For example, if either an individual who is involved in
a matter, or who is in a position to influence a related decision-making process through the
procedures laid down within the Agency, or a member of their family, owns shares in a
Doc: ED/28/2014 5(11)
Public
company involved in the matter, this fact should be made known immediately to the
process owner of the process concerned.
4. PROCEDURE TO UPDATE THE DECLARATION OF INTEREST
The respective secretariats of the Management Board, the Committees and of the Forum will
keep a register of all declarations made and will be in contact with the individual members
to ensure that the annual declarations are made. For ECHA staff, the Human Resources
(HR) unit will keep a register of declarations and ensure that annual updates are made. For
the Board of Appeal, the Chair will manage the register of declarations and ensure the
annual updates.
In the case of any member of the Management Board, the Committees, the Forum or the
Board of Appeal, or any ECHA staff member wishing to review and update their declaration
of interests between two annual updates, for instance when relevant changes have
occurred, they should contact the respective secretariat or the HR unit (for staff members).
5. WHAT TO DECLARE?
5.1 Definition of a conflict of interest
There is a conflict of interest where the impartiality and objectivity of a decision, opinion or
recommendation of the Agency and/or its bodies, is or might in the public perception be
compromised by an interest held by, or entrusted to, an individual working for the Agency.
More specifically, this means that a conflict of interest can arise if private interests of those
involved in the activities of ECHA interfere with the work of the Agency and its duty to take
impartial and objective decisions in the public interest. A conflict of interest situation can
also exist if personal interests are perceived by others as interfering with the work of ECHA
and, thus, undermining the public’s trust in the integrity of the Agency and its work.
5.2 Definition of other elements
All interests that may interfere with the work of the Agency and its duty to take impartial
and objective decisions in the public interest shall be declared.
Timeframe: all current interests and those that existed during the last 5 years. One should
count 5 years from the date of submitting the declaration.
For interests held by close family members, investments and intellectual property rights,
only current interests need to be declared.
Family ties: all current interests held by any members of the declarant’s household
(spouse, partner and dependent children) should be declared.
The names of the members of the declarant’s household do not need to be declared and the
declaration shall be limited to the interests that the declarant is aware of to the best of
his/her knowledge.
Staff members should also recall that Article 13 of the Staff Regulations creates an
obligation for them to inform the Appointing Authority of their spouse’s employment
situation.
Commercial entity: includes any commercial business, consultancy, research institute or
other enterprise, whose funding is significantly derived from commercial sources. It also
includes independent own commercial businesses, law offices, consultancies or other.
Doc: ED/28/2014 6(11)
Public
Organisation: includes governmental, international and non-profit organisations active in
the regulatory field of activity of ECHA, as well as interest groups (i.e. organisations and
self-employed individuals engaged in activities carried out with the objective of directly or
indirectly influencing the formulation or implementation of policy and decision-making
processes of the Agency).
The regulatory field of activity of ECHA: all interest that may interfere with the work of
the Agency shall be declared. This means that all interests in a commercial entity or other
organisation which is subject to the authority of ECHA (i.e. duty-holders under REACH, CLP,
Biocides or PIC) or which has dealings with ECHA shall be declared.
Only direct interests in duty-holders are considered and not interests in (potential)
competitors or (potential) co-registrants.
The above means that interests in e.g. IT companies do not need to be declared, not even
by the Director of Information Systems, as possible conflicts of interest in this field only
become relevant for procurement procedures for instance, while strict controls and specific
mitigating measures are in place for preventing any such conflicts in this process (e.g. via
specific declarations to be signed by all procurement panel members, etc.).
Confidential interests: when bound by a professional or contractual duty of secrecy, for
instance with regard to former clients represented (e.g. as lawyer or consultant), one shall
only declare the employment with the law firm or consultancy firm concerned. The declarant
shall then proactively make a specific declaration of absence of conflict of interest, each
time a task is assigned to him/her related to a former client operating in the regulatory field
of activity of the Agency. In some instance also the identity of substances worked on can be
considered confidential, in which case they do not need to be included.
5.3 Employment, consultancy, legal representation or advice
Employment is to be interpreted as covering all forms of employment (also self-
employment), part-time and full-time, either paid or unpaid, in any organisation (profit or
non-profit, public or private) whose activities fall within the regulatory field of activity of
ECHA.
Consultancy, legal representation or advice within the regulatory field of activity of ECHA,
regardless of whether they charge a fee or not, is to be considered as well. Any contracts or
collaborations with ECHA should also be specified. As stated above, the obligation to declare
shall not prejudice any professional or contractual duty of secrecy with regard to the
identity of (former) clients or substances worked on.
For members and invited experts of ECHA bodies, all current employment with a Member
State Competent Authority shall also be covered. For ECHA staff members, outside activities
which have been previously authorised by the Agency shall also be mentioned here.
Information about subsidiaries/parent companies of a former employer shall be declared,
but only to the extent that such corporate links are known to the declarant.
5.4 Membership of a Governing Body, Scientific Advisory Body or equivalent
structure
Membership of a Governing Body is to be interpreted as any participation in the internal
decision-making (e.g. board membership, directorship) of a public or private organisation or
commercial entity operating in the regulatory field of activity of ECHA.
Doc: ED/28/2014 7(11)
Public
Participation in a scientific advisory body is to be interpreted as meaning that the person
concerned is participating or has participated in the works of a scientific advisory body
operating in the regulatory field of activity of ECHA with a right to vote on the outputs of
that entity (e.g. voting on scientific output adopted by that entity).
For this purpose the fact of whether this activity is remunerated or not is irrelevant.
5.5 Other membership or affiliation
This shall include active membership of or involvement in any organisation relevant to the
regulatory field of activity of ECHA, other than the above. This shall in particular concern
membership of interest groups (i.e. organisations engaged in activities carried out with the
objective of directly or indirectly influencing the formulation or implementation of policy and
decision-making processes of the Agency). However, membership of bodies established
under public law serving a public interest (e.g. universities), in a religious group, a political
party, a trade union or comparable entity does not need to be declared.
Active membership or involvement shall include the making of donations beyond the regular
membership fee; active participation to events or other contributions to activities; active
involvement in the internal working of the organisation; et cetera.
5.6 Research funding
This includes any funding for research provided by a private or public entity, including
grants, rents, sponsorships and fellowships and received in a personal capacity or via the
research entity to which one belongs (as long as it is related to projects to which the
declarant has or had direct links) and falling within the regulatory field of activity of ECHA.
Non-monetary support is also envisaged (e.g. equipment, facilities, research assistants,
paid travel to meetings, et cetera). The declarant is requested to specify the estimated
value if possible.
5.7 Investments
A conflict of interest would arise if an individual working with ECHA were to handle a matter
or otherwise take part in a decision-making process (including through consultation)
involving a commercial entity in which the person(s) concerned holds securities or otherwise
has a financial interest.
For ECHA staff members, such situations are expressly covered by Article 11a of the Staff
Regulations. Paragraph 3 states: “He [the official] may neither keep nor acquire, directly or
indirectly, in undertakings which are subject to the authority of the institution to which he
belongs or which have dealings with that institution, any interest of such kind or magnitude
as might impair his independence in the performance of his duties.”
Consequently, the Agency has decided that the holding of a current financial interest of
more than 10,000 EUR per commercial entity is considered as such a substantial value that
it should be declared. In addition and notwithstanding their financial value, holding of
shares, stocks or comparable amounting to a voting right of 5 % or more in a company,
should be declared. Several investments in the same commercial entity made by different
persons in the same household shall be counted together for calculating the threshold.
Interests below the threshold are to be declared on a voluntary basis. In view of frequent
changes in the price value of such investments one shall update the declaration when the
price has been fixed for a certain period of time above the threshold. The declarant is
requested to specify the estimated value at the time of submission.
Doc: ED/28/2014 8(11)
Public
The term ’financial interest’ or ‘investment’ shall mean any financial interest in undertakings
which are subject to the authority of ECHA or which have dealings with ECHA, including the
holding of stocks and shares, stock options, equity, bonds, and/or partnership interest in
the capital of such an undertaking. This includes ’financial interests’ or ‘investments’ in a
subsidiary of the said undertaking or in a commercial entity in which the said undertaking
holds capital.
Partnerships in law-firms or other managerial stakes are to be considered as well, if not
already covered under one of the other sections (e.g. 5.3 or 5.4).
However, the holding of financial interest through an investment fund, pension fund and/or
interests in non-nominal unit trusts or similar arrangements would not, in principle, need to
be declared, provided that these investments are broadly diversified and the individual has
no influence on their financial management.
5.8 Intellectual Property
These are the rights granted to creators and owners of works that are the result of human
intellectual creativity and that pertain to a domain falling within the regulatory field of
activity of ECHA. These can be publications or can be in the industrial, scientific and artistic
domain. They can be in the form of an invention, a manuscript, a suite of software, or a
business name (e.g. copyrights, trademarks, patents, et cetera). Proprietary know-how in a
substance, technology or process can also be relevant. The declarant is requested to specify
the estimated value at the time of submission if possible.
5.9 Public statements and positions
Public statements should be interpreted as the provision of an expert opinion or testimony
in the regulatory field of activity of ECHA for a commercial entity or other organisation, as
part of a regulatory, legislative or judicial process.
Public office or other positions should be interpreted as the holding of an office or other
position, paid or unpaid, where the declarant represents interests or defends an opinion in
the regulatory field of activity of ECHA.
With regard to ECHA staff members who intend to stand for public office, or have been
elected or appointed to public office, Article 15 of the Staff Regulations establishes the
obligation to inform the Appointing Authority, who will decide whether and under what
modalities the staff member may continue to discharge his/her duties.
5.10 Other relevant information
In addition to the interests above, a declarant should declare any other interest or fact that
might prejudice their independence.
These other elements may for instance include:
- relevant interests held beyond the past 5 years;
- close personal relationships (such as those with adult offspring, parents or siblings, close
personal friendships, et cetera) and interests held by such individuals;
- the delivery of speeches or training for a commercial entity or other organisation with an
interest in the regulatory field of activity of ECHA, regardless of whether any payment was
provided;
Doc: ED/28/2014 9(11)
Public
- continuing rights of return to previous employment or positions and standing offers or
agreements about future employment;
- gifts received exceeding 50 EUR (including travel, hospitality or other forms of valuable
benefit).
Doc: ED/28/2014 10(11)
Public
ANNEX - SPECIFIC PRIVACY STATEMENT
for processing of personal data related to
Declarations of Interests
The ECHA Procedure for Prevention and Management of potential Conflicts of Interest
foresees that all individuals working for the Agency shall declare any interests which could
be considered to be prejudicial to their independence. As a consequence a lot of personal
data needs to be provided to the Agency. Below you will find more information about the
processing and the Data Protection safeguards put in place by the Agency to make sure any
processing of your personal data is in line with Regulation (EC) No 45/2001 on the
protection of individuals with regard to the processing of personal data by the Community
institutions and bodies and on the free movement of such data.
What is the legal basis for processing your personal data?
For the Executive Director and for members of the ECHA bodies (Management Board,
Committees, Forum and the Board of Appeal), the legal basis for processing personal data
contained in the declarations of interests is foreseen in Articles 87, 88 and 90 of the REACH
Regulation, while for the staff of the Agency, Articles 11-17 of the Staff Regulations lie at
the basis of this obligation. For both groups, as well as for any other individual working for
the Agency, reference can also be made to the Management Board decision adopting the
Procedure for Prevention and Management of potential Conflicts of Interests
(MB/07/2014/final).
What is the purpose of the collection of personal data?
Any personal data shall be collected and processed solely for detecting potential conflicts
between the private interests held by the individuals working for the Agency and the duty of
the Agency to make impartial and objective decisions, opinions and recommendations.
What personal data is collected?
Name and position in the ECHA organisation and private interests held, or entrusted to, the
individuals working for the Agency, including those of their close family members (spouse,
partner and/or dependent children).
Who has access to your personal data and to whom is it disclosed?
For transparency purposes the declarations of interest of the main actors behind ECHA’s
decision- and opinion-making are made available to the general public. The declarations of
the members of the ECHA bodies and of the ECHA management staff are published on the
ECHA website.
The declarations of interest submitted by the ECHA staff are stored in an electronic register,
managed by the Human Resources (HR) Unit, and to which the process owners (and
possible delegates) and line managers of the staff concerned have access. This allows the
managers to make an informed decision when assigning tasks to the staff under their
supervision.
If the specific case warrants it, the Executive Director may decide to consult the Conflicts of
Interest Advisory Committee to advise on how to handle a potential conflict of interest.
Doc: ED/28/2014 11(11)
Public
Furthermore, declarations may be transferred to bodies in charge of a monitoring or
inspection task in conformity with Community law, including the European Court of Auditors,
the Internal Audit Service, the Internal Audit Capability, OLAF, the European Ombudsman
and the European Data Protection Supervisor.
Who is the data controller?
With regard to the ECHA bodies, the respective secretariat shall exercise the tasks of the
data controller. For what the ECHA staff is concerned, it shall be the Head of the Human
Resources Unit who is the controller. Please use the respective functional mailboxes for any
questions:
-
[email protected]
-
[email protected]
-
[email protected]
-
[email protected]
-
[email protected]
-
[email protected]
-
[email protected]
-
[email protected] (for staff)
How long are your personal data kept?
The declarations of interest submitted by the members of the ECHA bodies and by the ECHA
staff members are entered into a register kept by the respective secretariats. As annual
renewal of these declarations is required, old declarations are removed from the above
mentioned register, but stored and archived by the secretariats for auditing purposes for a
maximum period of 5 years after the discharge for the budgetary year to which the
declaration relates, after which they are destroyed.
What are your rights?
Anyone submitting a declaration of interest has the right to access it and to update or
correct it at any time. To exercise these rights, contact the respective data controller via the
above mentioned functional mailboxes.
If you feel your Data Protection rights have been breached you can file a complaint with
ECHA’s Data Protection Officer (
[email protected]) or have recourse
to the European Data Protection Supervisor.
Management Board Decision 09/2014 1(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
DECISION OF THE MANAGEMENT BOARD
ON THE PREVENTION AND MANAGEMENT OF POTENTIAL
CONFLICTS OF INTEREST
1. Purpose
The management of (potential) conflict of interest situations is a key element of governance
and management of every EU institution, body or agency and crucial for maintaining the trust
of stakeholders and citizens in its integrity. Effective management of conflicts of interest and
assuring legality and regularity of its processes is thus a crucial requirement if ECHA wants to
play a pivotal role in ensuring that chemicals legislation and the decision-making processes
and scientific basis underlying it have credibility with all stakeholders and the public. For this
reason it is vital to ensure ECHA’s independence and transparency. 1
In order to achieve this, ECHA has to strike a delicate balance between getting the right
expertise to guarantee high quality science-based decision making and at the same time
strictly avoiding conflicting interests influencing or seen as influencing the decision-making
process. Important tools to achieve this balance are awareness raising, methods for detecting
risks to the Agency’s integrity, the establishment of clear boundaries for (un)acceptable
interests and the appropriate management of conflict of interest situations, including
underlying clear procedures. In this, it is not so much a matter of eliminating any possibility of
conflict of interest, but of detecting them at an early stage, recording them and handling them
appropriately.
2. Scope
This Procedure document applies to the entire ECHA organisation and all of its activities,
whether administrative or scientific in nature. The scope thus includes all members, their
advisers and invited experts of the ECHA bodies and networks, including the Board of Appeal,
the observers participating to their meetings, the statutory staff of the ECHA Secretariat and
any contractors working for the Agency.
3. Description
3.1. General principles
3.1.1. Independence and impartiality
Independence from all external interests is one of the core values of the Agency. In all of its
processes ECHA shall ensure that it is independent from all external interests and that
impartial and science-based decisions are taken. To achieve this, detailed guarantees and
checks need to be implemented in the processes of the Agency.
1
See also recital 95 of Regulation (EC) No 1907/2006 (the “REACH Regulation”).
Page 1 of 16
Management Board Decision 09/2014 2(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
3.1.2. Transparency
Transparency is another core value of ECHA and is strongly embedded in its founding
Regulation 2. Decisions and opinions are formed as openly as possible. For this reason,
declarations of interest of the main actors behind ECHA’s decision- and opinion-making are
made available to the general public.
3.1.3. Confidentiality
Article 105 of the REACH Regulation imposes on the members of the Management Board, the
Committees and the Forum as well as on all staff members of the Agency the duty not to
disclose information of the kind covered by the duty of professional secrecy, and this even
after their duties have ceased. This confidentiality duty is also included in the respective Rules
of Procedure of the ECHA bodies and a written declaration of confidentiality is required (the
same applies to the advisors, invited experts and observers) 3. For the ECHA Secretariat staff
also Articles 17 and 19 of the Staff Regulations impose a duty of strict confidentiality. The
confidentiality duty shall furthermore also imply that the individuals working for the Agency
shall not seek to gain any improper advantages from the information to which they have
access and that is covered by the duty of professional secrecy. The management of conflicts of
interest is also an element for preventing information leaks.
3.1.4. Awareness
As the Agency’s role is to promote the public interest in an independent and transparent
manner with respect for confidentiality rules, it is crucial that the individuals working with the
Agency understand that the exercise of public authority comes with certain duties. The Agency
shall support these individuals in fulfilling their duties, raise awareness, organise training and
set up further implementing procedures for identifying and handling conflict of interest
situations.
3.2. Preventing conflicts of interest
The first responsibility with regard to preventing conflicts of interest and with respect to
confidentiality rules shall lie with the public officials and other individuals working for the
Agency. To this effect, they must submit and keep up-to-date declarations of interest
compliant with the template in annex 1.
3.2.1 Before working for the Agency
For the positions for which the ECHA Management Board is the Appointing Authority, it has
adopted eligibility criteria (MB/45/2013 final) with which candidates for the position of
Executive Director, Accounting Officer, member of the Board of Appeal or member in the
Committee for Risk Assessment and the Committee for Socio-economic Analysis have to
comply to be considered for appointment.
To this end, such candidates are invited to fill in a declaration of interest already after inclusion
on the list of candidates proposed by the Commission or after their nomination by their
respective Member State, but before their appointment by the Management Board.
2
See for instance recital 95 and Articles 77(2) (e) to (n), 106 to 109 and 117 to 119 of the REACH Regulation.
3
See Article 10 of the respective Rules of Procedure of the Committees and of the Forum and Article 13 of the Rules of
Procedure of the Management Board.
Page 2 of 16
Management Board Decision 09/2014 3(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
For the positions for which the ECHA Management Board is not the Appointing Authority
(membership in the Management Board, the Member State Committee, the Biocidal Products
Committee and the Forum), the Management Board has adopted eligibility guidelines
(MB/45/2013 final) to which the relevant Appointing Authorities are invited to adhere, with the
exception of the Commission when appointing the three Management Board members to
represent interested parties.
In line with Article 11 of the Staff Regulations, before recruitment, all candidates for a position
in the Agency as statutory staff member are requested to make a written declaration of
interest in order for the Appointing Authority to be able to assess any potential conflicts of
interest in relation to the specific position that may be offered and to take appropriate
mitigating measures if necessary.
3.2.2 While working for the Agency
ECHA bodies and ECHA Secretariat
Annual declarations
According to Article 88(2) of the REACH Regulation, all members of the Management Board
and of the Committees and the Forum shall, when taking up their duties, make a written
declaration of interest which could be considered to be prejudicial to their independence. Also
all members of the Board of Appeal are required to make an annual declaration of interest in
writing.
The initial declarations are renewed annually. The secretariat of the respective ECHA body is in
contact with members in order to ensure that regular updates are provided. If at any point in
time changes occur to the situation of the member’s interests, he/she makes an updated
declaration without delay.
The respective secretariat of the ECHA body shall enter the declarations of interest in a
register, which is also published on the ECHA website. Subsequently, the respective secretariat
and chair shall monitor the declarations regularly to identify potential risks and handle
situations of potential conflicting interests in compliance with the present procedure (see
further under chapter 3.3.) and specific implementing rules. The respective secretariat shall
also undertake sample checks to guarantee the accuracy and completeness of the declarations
submitted by the members of the ECHA bodies.
Upon entry into the service at the Agency, the duty to declare all interests annually which is
imposed on the Executive Director by the REACH Regulation is extended to all staff of the
Agency. Besides filling in an initial declaration at the start of their employment, all staff
members shall thus provide an annual update of this declaration. For the management staff
(Executive Director, Directors and Heads of Unit) and the chairpersons of the ECHA
Committees, these declarations shall be published on the ECHA website.
If at any point in time changes occur to the situation of the staff member’s interests, the
person involved must update his/her declaration without delay.
Specific declarations
At each meeting the Management Board members and the members of the Committees and
the Forum (and their advisors), observers and any experts participating in the meeting are
explicitly asked by the chair to declare any interests which could be considered to be
prejudicial to their independence with respect to any of the points on the agenda. Such
Page 3 of 16
Management Board Decision 09/2014 4(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
conflicting interests are recorded in the minutes together with the specific mitigating measures
imposed (see also chapter 3.3).
When a Committee member is appointed as Rapporteur or Co-Rapporteur, he or she needs to
make for each case a written declaration of absence of conflict of interest in line with Article
87(1) of the REACH Regulation. A member of a Committee is not appointed rapporteur for a
particular case if he/she indicates any interest that might be prejudicial to the independent
consideration of that case.
The members of the Board of Appeal are required to make an ad-hoc declaration for each
specific case before the allocation of that case to them.
If at any point in time the staff member’s independence to work on a specific dossier is at risk,
the person involved must declare the specific interest in the dossier at hand to the process
owner of the process in which he/she operates.
Networks and expert groups
Several networks and expert groups support the Agency in its work. As these networks and
expert groups have a balanced composition, and as they are only advisory bodies, the risk of
conflicting interests affecting the formal work of ECHA is minimal. However, it shall be a
standard practice that the person chairing these meetings requests, when relevant, that any
conflicting interests are declared at the start of each meeting and documented in the minutes.
Where necessary, ECHA may also impose other preventive measures, including e.g. annual
declarations of interest.
Observers
As set out above, ECHA welcomes the attendance of observers of the stakeholder
organisations at the meetings of the Committees, the Forum and informal ECHA networks
selected by the respective body or network. These stakeholder observers have to comply with
the Code of conduct for observers 4 and need to declare any interest in the cases dealt with by
the respective Committee or network at the start of the meeting.
Furthermore, the Rules of Procedure of an ECHA body may foresee the possibility to invite case
owners or applicants to participate in a meeting or part of it as observers. As these case
owner/applicant observers clearly are attending the meeting to defend the interests of their
organisation in a particular dossier, it is unnecessary that they make a declaration of interest.
Strict compliance with the applicable Code of conduct shall be enforced 5.
Contractors
Whenever the Agency is contracting external service providers to support it in its tasks, it shall
ensure that these contractors are bound by confidentiality duties and that potential conflicts of
interest are avoided. Both a confidentiality clause and a conflict of interest clause are included
in all such contracts that ECHA concludes. Based on those contractual provisions, the Agency
may require external consultants (regardless of him/her working intra-muros or not) or interim
4
Code of conduct for observers at ECHA meetings (ED/62/2008).
5
See ECHA Code of conduct for case owners of evaluation draft decisions as observers at meetings of the Member
State Committee (ED/89/2013) and ECHA Code of conduct for applicants participating in the Biocidal Products
Committee and its Working Groups (ED/104/2013).
Page 4 of 16
Management Board Decision 09/2014 5(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
staff to make a specific declaration of interest with regard to the work performed for ECHA, in
case their participation has a qualitative impact on the decision-making at the Agency.
3.2.3 After work for the Agency has ended
Members of the ECHA bodies, staff members of the Agency, members of networks or expert
groups, observers and third parties working with the Agency shall be required, even after their
duties have ceased, not to disclose information of the kind covered by the duty of professional
secrecy 6.
When a staff member leaves the service at ECHA, he/she shall continue to be bound by the
duty to behave with integrity and discretion as regards the acceptance of certain appointments
or benefits. They shall be reminded of their duties under the Staff Regulations and shall duly
sign a document regarding integrity, discretion and confidentiality.
Furthermore, when leaving the Agency service, former ECHA staff have to notify the Agency
for a period of two years any new occupational activity they intend to engage in. If that activity
is related to the work carried out by the staff member during the last three years of service
and could lead to a conflict with the legitimate interests of the Agency, the Appointing
Authority can, if needed, either forbid the former staff member from undertaking it or give its
approval subject to any conditions it thinks fit (Article 16 Staff Regulations).
3.3. Identifying and Handling potential conflicts of interest
3.3.1. General assessment criteria
The interests to be assessed shall include all private interests in the field of activity of the
Agency, and more in particular employment, consultancy, legal representation or advice;
membership of a governing body or scientific advisory body; other memberships and
affiliations; research funding; investments; intellectual property; public statements and
positions and any other interests that may interfere (or may be seen as interfering) with the
work of the Agency (see annex 1, declaration of interest template).
When assessing whether certain of the above interests held by an individual working for the
Agency are to be considered as constituting an actual or perceived conflict of interest, the
following minimum criteria shall be taken into account:
• Not only personal interests, but also all relevant interests held by close family members
(i.e. members of the same household: spouse, partner and dependent children) need to
be considered;
• Not only current interests, but also those that existed during the last 5 years preceding
the assessment shall be considered (with an exception for investments, intellectual
property and interests held by close family members for which only current interests
are of relevance);
• All financial investments in a commercial entity that amount to a value above 10,000
EUR per company or shares, stocks or comparable amounting to a voting right of 5% or
more in a company (notwithstanding their financial value) are to be considered;
Besides these minimum criteria, the assessor (chair of ECHA body, line manager/process
owner for ECHA staff) shall take into account the other elements of the case, including the
importance of the interest declared, the role of the individual holding the interest, specific
6
See e.g. Article 105 of the REACH Regulation and Article 12 of ED/62/2008.
Page 5 of 16
Management Board Decision 09/2014 6(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
mitigating measures and controls imposed, the importance and impact of the decision or
opinion to be drafted, the availability of alternates or other experts, etc.
3.3.2. Mitigating measures for case-specific conflicts of interest
Management Board, Committees and Forum
Members who have not submitted the annual declaration of interest shall not take part in
meetings of the ECHA body and its working groups or decisions by written procedure.
The annual declaration of interest of the Executive Director is reviewed by the Chair of the
Management Board.
It shall be the task of the respective secretariat to regularly monitor the annual declarations
made by the members and to bring any potential conflict of interest to the attention of the
respective chair. The Executive Director shall also be informed of any such cases. On the basis
of the type and nature of the potential conflict identified, the chairperson shall decide on the
appropriate level of participation in the work of the ECHA body.
Furthermore, the chair will ask members and their advisors as well as invited experts and
observers to declare any interests at the beginning of each meeting and any declared interests
will be recorded in the minutes. On the basis of the type and nature of the potential conflict
identified, the chairperson shall decide on the appropriate level of participation. This applies
accordingly for the cases of written procedures in ECHA bodies. As a minimum, such person
shall not participate in any voting on the relevant agenda point (see Article 88(3) of REACH).
Such person shall also not transfer his/her voting right by proxy to another member, which
does not preclude the replacement by an alternate. The member concerned shall also not be
appointed as (co-)rapporteur for a particular case if he indicates any conflicting interests (see
Article 87(1) of REACH).
Additionally, where further steps are deemed necessary, the chair shall at least have at his/her
disposal any of the following instruments to mitigate the issue:
• The member concerned can participate to the discussions but shall not participate to
the final deliberations on the relevant agenda point;
• The member concerned shall not participate to the discussions or final deliberations
on the relevant agenda point;
• The member concerned is to leave the room for the duration of the relevant agenda
point;
• The member concerned shall participate only as an expert witness in order to testify
and give specialist advice on a specific issue by providing information and replying to
any questions;
• In the case that an alternate can be appointed in the pertinent ECHA body, the
member concerned may be replaced by his/her alternate for the relevant agenda
point;
• Where the Chair is concerned, he/she is to be replaced for the relevant agenda point.
Board of Appeal
The annual declarations of the Board of Appeal members are monitored by its Chair. The
Chairman’s declarations are monitored by the longest serving member of the Board of Appeal.
Specific, case-related declarations by a member of the Board of Appeal are assessed by the
other Board of Appeal members, who shall decide as to the action to be taken.
Page 6 of 16
Management Board Decision 09/2014 7(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
If a member of the Board of Appeal considers that because of a conflict of interests he must
not take part in the specific legal proceedings, he shall inform the Board of Appeal accordingly.
The Chairman may replace that member by an alternate.
Likewise, members of the Board of Appeal may be objected to by any party to the appeal
proceedings on the grounds of possible conflicts of interest. In this situation, the Board of
Appeal shall decide as to the action to be taken without the participation of the member
concerned. For the purpose of taking this decision, the member concerned shall be replaced by
an alternate. 7
ECHA Secretariat
The process owners shall, based on a risk assessment, define the processes in the Agency that
require interest management. In such processes, conflict of interest checks shall be performed
each time a staff member is assigned to a role in the process. Such interest checks are
performed on the basis of the annual and specific declarations made by the staff members
concerned and documented by the process owner. If there is a potential conflict of interest,
another staff member shall be assigned, unless appropriate mitigating measures are imposed
to guarantee the independent outcome of the procedure.
3.3.3. Mitigating measures for conflicts of interest of a general nature and breach of
trust
ECHA bodies
Any false declaration, wilful omission or refusal to declare interests or any other failure to
comply with this procedure may be seen as a breach of trust towards the Agency. The same
applies for any persistent conflict of interest which seriously hampers the functioning of the
ECHA body.
The respective chair of the ECHA body can decide on remedial actions to address an alleged
breach of trust. In case the remedial actions do not bring the expected outcome, the chair in
consultation with the Executive Director shall send a formal notification to the Appointing
Authority 8 stating the nature of the problem.
The respective Appointing Authority is responsible for adopting any formal decision as a
consequence of a (potential) conflict of interest when they are informed of a situation which
may be detrimental to the Agency. Such decision may vary from a letter of reprimand to the
request or duty to resign or the revocation of the nomination / appointment.
The members of the Board of Appeal may not be removed from office unless there are serious
grounds and only by decision of the Commission, after obtaining the opinion of the
Management Board.
7
See Article 90 (5)-(7) REACH Regulation.
8
For the Management Board the appointing authority is either the European Council (for the members nominated by
the Member States), the Commission or the Parliament (Article 79 REACH Regulation). The appointing authority for
the Member State Committee, the Biocidal Products Committee and the Forum are the respective Member States
(Article 85(3) and 86 REACH Regulation and Article 75(2) BPR), while for the Board of Appeal, the Committee for Risk
Assessment and the Committee for Socio-economic Analysis the appointing authority is the ECHA Management Board
or the Committee in the case of co-opted members.
Page 7 of 16
Management Board Decision 09/2014 8(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
In case the Executive Director is not satisfied with the remedies put in place by the chair or by
the Appointing Authority, he/she shall inform the ECHA body concerned of this fact in its next
meeting and have it noted in the minutes of the meeting.
Anyone affected by a decision of the chair of an ECHA body to implement remedial actions can
request the Chair of the Management Board for a review of such decision. The Chair of the
Management Board, in consultation with the Executive Director, shall decide on the follow-up,
with the possibility to consult the Conflicts of Interest Advisory Committee.
ECHA staff
Any persistent conflict of interest that may hamper the proper functioning of an ECHA staff
member in his/her current function shall be assessed by the respective line managers and
escalated towards the Appointing Authority for decision if necessary. Where necessary,
appropriate mitigating measures will be implemented (e.g. change in task description, move to
another position in the interest of service, etc.) 9. The Appointing Authority shall have the
possibility to consult the Conflicts of Interest Advisory Committee before deciding on the action
to take.
Any false declaration or wilful omission of potential conflicts of interest, as well as the refusal
to declare interests may result in disciplinary action under the Staff Regulations.
Ex-post review
If the person concerned by an established breach of trust was involved in an opinion- or
decision-making procedure, the Agency may carry out an ex post review of the person's
activities and contributions to the Agency's output.
3.3.4. Conflicts of Interest Advisory Committee
A Conflicts of Interest Advisory Committee (CoIAC) is established as an advisory body in the
context of this Procedure. It is available to the Management Board, the Committees and the
Forum as well as to the Executive Director for advice on matters related to (potential) conflicts
of interest of individuals staffing the Agency or members of its bodies. It is composed of the
Head of the Legal Affairs unit of the Agency, Chair, of a person designated by the Management
Board and of an outside expert designated by the Executive Director for its competence in the
field of conflicts of interest.
The Executive Director can consult the CoIAC in all stages of the process of handling a
potential situation of conflicting interests, to seek their advice on the individual case at hand.
The chair of any of the ECHA bodies can also request the Executive Director to consult CoIAC.
On request of the Executive Director, possibly prompted by the chair of an ECHA body, the
CoIAC issues a reasoned advice, without prejudice to the decision-making powers of the
Agency body requesting it.
For issues related to the Board of Appeal, the Management Board has established a standing
working group. This working group can also provide advice on issues related to (potential)
conflicts of interest. Where necessary and as appropriate, the working group may ask the
Chair of the Management Board to consult the CoIAC in order to guarantee consistency in the
application of conflict of interest criteria within the Agency.
9
For the regular members of the Board of Appeal (who are also ECHA staff) the provisions of Article 90 of the REACH
Regulation will apply.
Page 8 of 16
Management Board Decision 09/2014 9(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
3.4. Further implementation
As the legal representative of the Agency and responsible for the daily management of the
Agency, the Executive Director shall adopt implementing rules to this policy, containing the
detailed procedures for preventing and handling conflicts of interest. He/she shall regularly
report on the implementation of the policy to the Management Board and in the annual activity
report of the Agency.
The ECHA bodies shall include detailed provisions for the implementation of this procedure into
their respective Rules of Procedures, Codes of Conduct and working procedures. Where
necessary and if applicable, the chair may decide to impose the same requirements on the
regular members of working groups established by the respective ECHA bodies.
The staff of the ECHA Secretariat shall further comply with all other obligations that are
imposed on them by the Staff Regulations (see Articles 11 to 19) and its implementing rules.
Done at Helsinki, 20 March 2014.
signed
For the Management Board
Nina Cromnier
Page 9 of 16
Management Board Decision 09/2014 10(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
4. Definitions
Term or abbreviation Definition
Breach of trust Any false declaration, wilful omission or refusal to declare interests
or any other failure to comply with the agency's conflict of interest
policy.
Conflict of interest There is a conflict of interest where the impartiality and objectivity
of a decision, opinion or recommendation of the Agency, including
its bodies, is or might in the public perception be compromised by
an interest held by, or entrusted to, an individual working for the
Agency.
ECHA body The ECHA bodies shall include the Management Board, the Member
State Committee, the Risk Assessment Committee, the Committee
for Socio-economic Analysis, the Biocidal Products Committee, the
Enforcement Forum and the Board of Appeal.
ECHA Secretariat The ECHA Secretariat works under the leadership of the Executive
Director and provides technical, scientific and administrative
support for the Committees and the Forum and ensures appropriate
coordination between them. It shall also undertake the work
required of the Agency under the procedures for pre-registration,
registration and evaluation as well as preparation of guidance,
database maintenance and information provision (Article 76.1(g) of
REACH)
Process owner A process owner is a person (staff member of the ECHA
Secretariat) designated by the Executive Director, responsible for
the efficient and effective functioning of the process and has the
necessary authority to take action or make decisions with an impact
on the process performance. In general, the process owner ensures
that proper action is taken with respect to the implementation,
maintenance, control and improvement of the process.
5. Annexes
Annex 1 - Template for Declaration of Interest
Page 10 of 16
Management Board Decision 09/2014 11(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
Annex 1 - ECHA DECLARATION OF INTEREST
There is a conflict of interest where the impartiality and objectivity of a decision, opinion or
recommendation of the Agency and/or its bodies, is or might in the public perception be
compromised by an interest held by, or entrusted to, an individual working for the Agency.
Please note that having an interest does not necessarily mean having a conflict of interest. In
particular, high quality of (scientific) expertise is by nature based on prior experience.
Declaring an interest does therefore not automatically disqualify you or limit your participation
in the activities of the European Chemicals Agency.
On the other hand it should be emphasised that this declaration of interest form does not
contain an exhaustive list of potential interests and that all other elements that might
jeopardise your independence when working with the Agency should thus also be indicated.
Your answers will then be reviewed and dealt with in accordance with the ECHA Procedure for
Prevention and Management of potential Conflicts of Interest.
First Name:
Last name:
Position in ECHA:
hereby declares to have the following interests:
Page 11 of 16
Management Board Decision 09/2014 12(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
I. Employment, consultancy, legal representation or advice
Within the past 5 years, were you employed or have you had any other professional
relationship with a commercial entity 10 or other organisation 11 with an interest in the
regulatory field of activity of ECHA?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation or
month/year) commercial
entity
II. Membership of Governing Body, Scientific Advisory Body or
equivalent structure
Within the past 5 years, have you participated in the internal decision-making of a commercial
entity or other organisation with an interest in the regulatory field of activity of ECHA (e.g.
board membership, directorship) or have you participated in the works of a Scientific Advisory
Body with voting rights on the outputs of that entity?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation or
month/year) commercial
entity
10
This includes any commercial business, consultancy, research institution or other enterprise whose funding is
significantly derived from commercial sources. It also includes independent own commercial businesses, law offices,
consultancies or similar.
11
An ‘organisation’ includes governmental, international or non-profit organisations, as well as interest groups.
Page 12 of 16
Management Board Decision 09/2014 13(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
III. Other membership or affiliation
Within the past 5 years, have you had any membership or affiliation other than the above that
can be perceived as creating a potential conflict of interest?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation or
month/year) commercial
entity
IV. Research funding
Within the past 5 years, have you or the research entity to which you belong received any
support from a commercial entity or other organisation with an interest in the regulatory field
of activity of ECHA, including grants, rents, sponsorships, fellowships, non-monetary support?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation or
month/year) commercial
entity
Page 13 of 16
Management Board Decision 09/2014 14(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
V. Investments
Do you have current investments in a commercial entity with an interest in the regulatory field
of activity of ECHA, including holding of stocks and shares, stock options, equity, bonds,
partnership interest in the capital of such undertaking, one of its subsidiaries or a company in
the capital of which it has a holding and which amounts to more than 10,000 EUR per
commercial entity or entitling you to a voting right of 5% or more in such commercial entity? 12
No
Yes, and more in particular:
Investment Name of organisation or commercial
entity
VI. Intellectual Property
Do you have any intellectual property rights (e.g. patent, trademark, copyright or proprietary
know-how) in the regulatory field of activity of ECHA that might create a potential conflict of
interest?
No
Yes, and more in particular:
Intellectual Property Name of Description
organisation or
commercial entity
12
You may exclude financial interests held through an investment fund, pension fund and/or interests in non-nominal
unit trusts or similar arrangements, provided that these investments are broadly diversified and you have no influence
on their financial management.
Page 14 of 16
Management Board Decision 09/2014 15(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
VII. Public statements and positions
Within the past 5 years, have you provided any expert opinion or testimony in the regulatory
field of activity of ECHA for a commercial entity or other organisation as part of a regulatory,
legislative or judicial process? Have you held an office or other position, paid or unpaid, where
you represented interests or defended an opinion in the regulatory field of activity of ECHA?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation or
month/year) commercial
entity
VIII. Other relevant information
Are there any other elements that could be seen as jeopardising your independence when
working for the Agency?
Page 15 of 16
Management Board Decision 09/2014 16(16)
Public (reference to document MB/07/2014)
20/03/2014
Effective date:01/04/2014
IX. Interests held by close family members 13
Does any of your close family members hold any current interests in the regulatory field of
activity of the Agency (as specified above in the sections I.-VIII.)?
Function/Activity Name of Description
organisation or
commercial
entity
I wish to have any reference to interests held by close family members removed if this
declaration is to be made public on the ECHA website. 14
I hereby declare that I have read both the ECHA Procedure on Prevention and
Management of potential Conflicts of Interest and the related ECHA Guidance
document and that the above Declaration of Interest is at my best knowledge
complete. I understand that for all members of the ECHA bodies, the Executive Director and
the other ECHA management staff (Directors and Heads of Unit), as well as for the
chairpersons of the ECHA Committees this declaration will be published on the ECHA website.
Please note that the European Chemicals Agency will ensure on its part that your personal data
hereby submitted is processed as required by Regulation (EC) No 45/2001 on the protection of
individuals with regard to the processing of personal data by the Community institutions and
bodies and on the free movement of such data. You have the right to access and rectify that
data. To exercise these rights, please contact the relevant secretariat.
Date: Signature:
(If you need more sheets to declare your interests, do not hesitate to use blank ones, but
please sign each one of them and attach them to this form.)
13
For this purpose ‘close family members’ are considered to be the persons forming a household with the person
making this declaration (spouse, partner, and/or dependent children). For privacy reasons neither the relationship nor
the name is to be included. Only current interests held by close family members are of relevance and not past
interests.
14
As full transparency is one of the general principles of this Procedure, this option should only be used in case the
consent of the individual concerned has not been obtained, when he/she has objected to the disclosure on compelling
legitimate grounds or if there is reason to believe that the legitimate interests of the individual involved might be
prejudiced by the disclosure (see also Regulation (EC) No 45/2001 on the protection of personal data).
Page 16 of 16
1 (10)
MB/25/2013 final1 2
Helsinki, 20.06.2013
Rules of procedure for the Biocidal Products Committee
Article 1
Responsibilities
In accordance with Article 75 of Regulation (EU) No 528/2012 the Biocidal Products
Committee (hereinafter, referred to as “the Committee”) shall be responsible for preparing
the opinion of the Agency in relation to the tasks set out in Article 2.
Article 2
Tasks
1. The Committee shall be responsible for preparing the opinion of the Agency on the
following issues:
a) Applications for approval and renewal of approval of active substances;
b) Review of approval of active substances;
c) Applications for inclusion in Annex I of active substances meeting the conditions laid
down in Article 28 of Regulation (EU) No 528/2012 and review of the inclusion of such
active substances in Annex I;
d) Identification of active substances which are candidates for substitution;
e) Applications for Union authorisation of biocidal products and for renewal, cancellation
and amendments of Union authorisations, except where the applications are for
administrative changes;
f) Scientific and technical matters concerning mutual recognition in accordance with
Article 38 of Regulation (EU) No 528/2012;
g) At the request of the Commission or of Member States’ Competent Authorities, any
other questions that arise from the operation of Regulation (EU) No 528/2012 relating
to technical guidance or risks to human health, animal health or the environment.
Article 3
Members and Alternates
1. In accordance with Article 75(2) of Regulation (EU) No 528/2012, each Member State
shall be entitled to appoint one member to the Committee.
2. Member States may appoint an alternate. Appointment of an alternate to the Commit t ee
shall be communicated to the Agency by the Member State concerned. This appointment
may take place at any point in time. The term of office of an alternate member starts
from the date of appointment. All other provisions of these Rules of Procedure for the
members are, where relevant, applicable also to the alternate members, except the
possibility of being nominated as rapporteur or co-rapporteur.
1 Amendment of Annex 2 approved by the Management Board on 20 March 2014.
2
Switzerland invited to participate in the biocides-related activities of the Agency by the Management
Board of 19-20 March 2015.
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
2 (10)
3. Members have the right to vote. Where relevant, alternates shall represent and vote for
the appointed member in the absence of the member from the meeting. At the request
of the member, the alternate may respond on behalf of the member in written procedures
or any request for urgent advice from members between meetings.
4. The members of the Committee appointed by a Member State shall ensure that there is
appropriate coordination between the tasks of the Agency and the work of their Member
State Competent Authority.
5. The members of the Agency’s Management Board may not be members of the
Committee.
6. Members and alternates appointed by Iceland, Liechtenstein and Norway 3 and by
Switzerland4 shall have the same rights and obligations as other members, except the
right to vote.
Article 4
Term of office and replacing members
1. In accordance with Article 75 (4) of Regulation (EU) No 528/2012 (which in turns refers
to Article 85(4) of Regulation (EC) No 1907/2006) the term of office of the members of
the Committee shall be three years starting from the date of appointment. The date of
appointment shall be the date of the first meeting of the Committee during this term of
office. The appointment shall be renewable.
2. A member’s term of office shall end before the expiry of the three-year period with their
resignation submitted in writing to the Agency and a letter from the Permanent
Representation of the Member State concerned to the Agency indicating another
appointment. The new member thus appointed shall serve for the remaining period of
the three-year term which started at the date of appointment referred to in paragraph 1.
3. In exceptional cases when members are prevented from participating in a meeting of the
Committee, they should notify the Agency and request the alternate, if one has been
appointed, to be invited by the Agency to participate in the respective meeting.
4. If prevented from participating in a meeting or from sending an alternate, if one has been
appointed, members of the Committee having the right to vote may vote by proxy. If
they wish to use this right, they should inform this to the Secretariat before the meeting.
In addition to their own vote, each member having the right to vote may cast a maximu m
of two votes by proxy. The proxy shall be notified to the Committee at the beginning of
the meeting and shall be recorded in the minutes.
Article 5
Co-opted members
1. In accordance with Article 75 (4) of Regulation (EU) No 528/2012 (which in turns refers
to Article 85(4) of Regulation (EC) No 1907/2006) the Committee shall aim to have a
broad range of relevant expertise among their members. To this end the Committee may
co-opt a maximum of five additional members chosen on the basis of their specific
competence.
2. The Committee may decide whether additional members should be co-opted and shall
agree on the required specific competences and on the selection procedure by two -thirds
majority of all members having the right to vote. These additional members can be co-
opted at any point in time.
3. Co-opted members shall be appointed for a term of three years and the date of
appointment will be determined by the Secretariat and the term of office will end at the
3 Subject to Regulation (EU) No 528/2012 being incorporated into the EEA Agreement.
4
In accordance with the revised Annex I, Chapter 18 of the Mutual Recognition Agreement (MRA, RS
0.946.526.81) between EU and Switzerland.
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
3 (10)
same time as the term of office of Committee members referred to in Article 4(1). The
appointment may be renewed by the Committee, if it decides that the specific competence
of the co-opted member continues to be necessary for the Committee.
4. A co-opted member’s term of office shall end before the expiry of the three -year period
if their resignation is submitted in writing to the Agency.
5. Co-opted members shall have the same rights and obligations as other members, except
the right to vote and right to appoint an alternate.
Article 6
Other participants at the meetings
1. The meetings of the Committee and its working groups as referred to in Article 18, unless
otherwise stated, shall be open to advisers, invited experts and observers, as specified
in paragraphs 2 to 10.
2. Advisers are participants of Committee meetings or its working groups accompanying
members to provide advice on scientific, technical or regulatory matters. The members
shall notify the names of their advisers to the Secretariat before the meeting which they
are due to attend.
3. Invited experts are experts in technical or scientific fields who can, upon proposal of a
member or the Secretariat, be invited by the Agency to participate for one or more points
of the agenda in a meeting of the Committee or its working groups.
4. Observers are other participants of the meetings of the Committee or its working groups
under paragraphs 5 to 10 who are not members, advisers or invited experts.
5. The Executive Director and his representatives and representatives of the European
Commission shall be entitled to take part in the meetings of the Committee and its
working groups as observers.
6. Nominated representatives of accredited stakeholder organisations may be admitted by
the Committee as regular observers to the meetings of the Committee or its working
groups upon request of the ECHA Management Board and agreement with members of
the Committee. These representatives contribute with their scientific and technical
expertise and ensure the multiplication of information within their sectors. These
accredited stakeholder observers shall conform to the Code of Conduct for Stakeholder
Observers at ECHA meetings, other rules specifying the procedure for the admission of
observers and any other applicable Agency rules.
7. An applicant 5 may be admitted as an observer when their specific case is addressed by
the Committee or its working groups. Applicants shall conform to any particular
applicable Committee rules, working procedures or codes of conduct that may be drawn
up by the Committee, or other applicable Agency rules.
8. Admittance to the meetings of the Committee or its Working Groups by nominat ed
accredited stakeholder organisations or applicants may be refused on a case -by-case
basis for reasons of confidential business information, including the protection of
intellectual property rights or for other justified reasons related to the information to be
discussed in a particular meeting.
9. Representatives of third countries and international organisations may take part in the
meetings as observers upon request by the ECHA Management Board and agreement
with the members of the Committee.
10. Other observers may be admitted upon request of a member of the Committee or of the
Chair.
5 For approval of an active substance or authorisation of a biocidal product.
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
4 (10)
11. The Committee shall agree by two-thirds majority of all members having the right to vote
on rules specifying the procedure for the admission of observers referred to in paragraphs
6 to 10.
12. The Chair may decide to hold the meeting in a closed session excluding observer(s)
referred to in paragraphs 6 to 10 at any point in time before or during a meeting on a
written or oral request of a member or when the Chair considers this otherwise
appropriate.
13. Invited experts and observers referred to in paragraphs 3 and 6 to 10 shall have the
same access as the members to the documents of the meeting or the documents for the
relevant agenda points in which they take part, except in relation to the issues that the
Chair identifies as confidential for reasons of confidential business information, including
the protection of intellectual property rights or for other justified reasons, or where their
participation is excluded. The access of advisers to documents is at the discretion of the
respective member.
Article 7
The Chair
1. In accordance with Article 75 (4) of Regulation (EU) No 528/2012 (which in turns refers
to Article 85(9) of Regulation (EC) No 1907/2006), the Committee shall be chaired by an
employee of the Agency.
2. If the Chair is absent or has a conflict of interest for an agenda item, the Executive
Director of the Agency will assign a replacement.
Article 8
Responsibilities of the Chair
The Chair is responsible for the efficient conduct of the business of the Committee and shall
in particular:
a) Plan the work of the Committee together with the members and ECHA support Unit(s);
b) Monitor that these Rules of Procedure are respected and propose measures in case of
breach;
c) Ensure that at the beginning of each meeting any potential conflict of interest is
declared regarding any particular item to be discussed by the Committee;
d) Ensure that the work of the Committee is consistent with its tasks indic ated in Article
75(1) of Regulation (EU) No 528/2012;
e) Endeavour to ensure, together with the Committee and the Secretariat, consistency
of the Committee’s work;
f) Ensure that all underlying argumentation is adequately reflected in the deliberations
of the Committee;
g) Co-ordinate together with the Secretariat the work of the Committee with that of
other Committees of the Agency as well as with other relevant European Union
committees or bodies;
h) Facilitate adoption of opinions within the set deadlines and endeav our to reach
consensus in the opinions of the Committee; and
i) Execute any additional powers entrusted to the Chair by the Committee.
Article 9
Independence
1. Pursuant to Article 75(4) of Regulation (EU) No 528/2012 (which in turns refers to Article
88(2) of Regulation (EC) No 1907/2006), members shall make a declaration of
commitment to fulfil their duties and a declaration of any interests which could be
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
5 (10)
considered to be prejudicial to their independence. The declarations shall be made 6 in
accordance with the models (direct links provided in Annex 1) and according to the
applicable ECHA Conflicts of Interest Policy. These declarations shall be made annually in
writing and be entered in a register held by the Agency. If at any point in time changes
occur to the situation of the member’s interests, they shall make an updated declaration
without delay. In addition, declarations of interests shall be published on the Agency’s
website without prejudice to Article 11(1). Members who have not submitted the
declaration of interests shall not take part in meetings of the Committee and its working
groups or decisions by writt en procedure. The Chair may impose the same requirement s
on members of working groups that are not Committee members.
2. According to Article 75(4) of Regulation (EU) No 528/2012 (which in turns refers to Article
88(3) of Regulation (EC) No 1907/2006), members, their advisers and invited experts
participating in the meeting shall declare at each meeting any interest which could be
considered to be prejudicial to their independence with respect to any point on the
agenda. Any members declaring such interests shall not participate in any voting on the
relevant agenda point. The Chair may decide if other measures are necessary.
3. According to Article 75(4) of Regulation (EU) No 528/2012 (which in turns refers to Article
87(1) of Regulation (EC) No 1907/2006), for each case, the rapporteur and, when
applicable, co-rapporteur shall undertake to act in the interest of the Union and shall
make a declaration of commitment to fulfil their duties and a declaration of interests in
writing.
4. A member of the Committee shall not be appointed as rapporteur or co -rapporteur for a
particular case if they indicate any interest that might be prejudicial to the independent
consideration of that case.
5. The Committee may agree to replace the rapporteur or co-rapporteur by another one of
its members at any time, if an interest that might be prejudicial to their independent
consideration of a case comes to light.
6. In general, the Chair represents the Committee including towards other parties.
Individual members can be mandated by the Chair to represent the Committee on specific
issues or occasions.
7. Without prejudice to Article 10(1), members have a duty to ensure any view relevant to
the work of the Committee they express outside of the Committee is presented as their
own view, unless mandated by the Chair.
8. Members have a duty to act in accordance with the applicable General Principles and
Guidance for Committee members of the Agency in relation to this Article and Article 10.
9. Following their appointment members shall at all times comply with the eligibilit y
guidelines applicable to the Committee.
Article 10
Confidentiality
1. Members, their advisers, invited experts and observers of the Committee and its working
groups shall not disclose to any persons other than representatives of relevant public
authorities of the Member States, the Commission and Union bodies, any informat ion
acquired as a result of their participation in work in the Committee unless otherwise
stipulated in Union or national law or already publicly available. Members, their advisers,
invited experts and observers of the Committee and its working groups shall make a
6 http://echa.europa.eu/documents/10162/13607/ed_decision_67_2011_en.pdf
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
6 (10)
written declaration of confidentiality in accordance with the model (direct link is provided
in Annex 1).
2. The obligation to maintain confidentiality shall continue to apply even after participation
of members, their advisers, invited experts and observers in the work or in the meetings
of the Committee has ceased.
Article 11
Transparency
1. In accordance with Article 75(4) of Regulation (EU) No 528/2012 (applies as mutatis
mutandis, Article 88(1) of Regulation (EC) No 1907/2006), the membership shall be made
public unless the Executive Director decides not to publish the appointment at a request
of an individual member.
2. The Committee shall operate in accordance with the need for a high level of transparency,
without prejudice to legitimate requests for confidentiality or the independence of
members, their advisers and invited experts.
3. The following documents of the Committee shall be published on the Agency’s web site,
without prejudice to confidentiality requirements:
- Rules of Procedure;
- Agreed minutes of plenary meetings in accordance with Article 16(1);
- Draft agendas;
- The annual declarations of interests in accordance with Article 9(1);
- The names of the members of the Committee together with their brief CVs.
4. With the exception of minority opinions, individual views, whether expressed orally or in
writing by members or other meeting participants during deliberations within the
Committee or a working group, shall not be ascribed to a particular individual unless this
is explicitly requested by the individual.
Article 12
Organisation of Committee meetings
1. The meetings of the Committee shall be convened either by an initiative from the Chair
or, where necessary, by the Executive Director following a request of a majority of the
members. The meetings are convened by means of a written invitation from the Agency.
2. The Secretariat will provide provisional dates for the following year at the earliest possible
time in the preceding year.
3. The invitation to an ordinary meeting shall be circulated well in advance, but no later
than 21 calendar days before the meeting.
4. In urgent cases when it is necessary to convene the Committee immediately, the
Executive Director may shorten the time limit for invitations to a minimum of five calendar
days before the start of the meeting.
5. The working language of the Committee is English.
Article 13
Agenda for ordinary meetings
1. A provisional draft agenda shall be drawn up by the Chair and circulated to the Commit t ee
together with the invitation to the meeting. The provisional draft agenda shall indicate if
an item is intended to be addressed in an open or closed session.
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
7 (10)
2. A revised draft agenda shall be established by the Chair and circulated no later than ten
calendar days before the meeting. The agenda shall be agreed at the beginning of each
meeting.
3. If the Committee so decides, urgent questions may be added to the agenda at any time
prior to the end of the meeting and items on the agenda may be deleted or carried over
to a subsequent meeting.
Article 14
Documentation for meetings
Documentation for meetings shall be made available as early as possible to allow preparation
for the meeting. With due consideration of their volume and complexity, documents shall be
made available no later than ten calendar days before the meeting. This period can be
shortened by the Chair in justified and exceptional cases. Unless the Committee otherwise
agrees, documents available less than ten calendar days before the meeting would be for
discussion or information only.
Article 15
Agenda and documentation for urgent meetings
The draft agenda and documents for an urgent meeting referred to in Article 12(3) shall be
circulated together with the invitation no later than five calendar days before the start of the
meeting.
Article 16
Minutes
1. Final minutes of plenary meetings shall include:
a) Any specific interests declared by the participants and follow -up actions to any
points of the agenda pursuant to Article 9(2);
b) A summary record of the proceedings;
c) Reference to the opinions reached by the Committee and their underlying
argumentation;
d) The list of attendees;
e) The action points and conclusions agreed at the meeting.
2. Draft minutes or relevant parts of it shall be distributed to participants of the meeting no
later than 28 calendar days after the meeting. Written comments shall be provided to the
Secretariat within a specified deadline which shall be a minimum of seven calendar days.
The minutes shall be agreed at the following meeting or by written procedure.
Article 17
Rapporteurs
1. Pursuant to Article 75(4) of Regulation (EU) No 528/2012, which in turn refers to Article
87(1) of Regulation (EC) No 1907/2006, where the Committee is required to provide an
opinion, where appropriate, it shall identify and appoint one of its members as a
rapporteur as early as possible. The Committee may appoint a second member to act as
co-rapporteur.
2. The rapporteur for an application as defined in Article 75(1) (a), (b) and (e) of Regulation
(EU) No 528/2012 shall usually be from the same Member State as the evaluating
Competent Authority (eCA).
3. For cases pertaining to Article 75(1) (g) of Regulation (EU) No 528/2012 the Commit t ee
shall appoint one of its members as a rapporteur and agree by two thirds majority of all
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
8 (10)
members present having the right to vote on the role and tasks of the rapporteur and
possible co-rapporteur.
4. If either the rapporteur or co-rapporteur are unable to fulfil their duties within the
prescribed time limits, the Committee may at any time agree to replace the rapporteur
or co-rapporteur by two thirds majority by another one of its members.
5. Notwithstanding the applicable provisions in the Fee Regulation, any remuneration from
the Agency of the rapporteur and co-rapporteur shall be based on the rules established
by the Management Board and laid down in a written contract between the Agency and
the person concerned or their employer.
6. The Committee may decide to designate a working group to support the rapporteur and
co-rapporteur in their task(s).
Article 18
Working groups
1. Where appropriate, the Committee may establish ad hoc or permanent working groups.
Working groups shall be chaired by the Secretariat and shall report to the Committee in
accordance with their mandate.
2. The mandate and composition of a working group as well as the duration of its activity
shall be determined and reviewed periodically by the Committee. The Commit t ee
agreement establishing the mandate shall be recorded in the minutes of the meeting.
3. Working groups may be composed of volunteering members of the Committee,
rapporteurs and/or other persons proposed by the Member State Competent Authorities
and other experts invited on the basis of the required expertise. Prospective members
and invited experts of the Working Group will receive an invitation from the Chair of the
Committee. The mandate and composition of the working groups shall be made public by
the Secretariat.
4. Draft agendas, meeting dates and minutes of the working group meetings shall be made
available to the Committee.
5. Working groups under the Committee shall apply these Rules of Procedure of the
Committee, as far as applicable.
6. Where appropriate, the Committee may establish with other ECHA Committees, a joint
working group by mutual consent. The provisions of paragraphs 2-5 shall apply mutatis
mutandis to the joint working group. The mandate referred to in paragraph 2 shall specify
the applicable rules of procedure referred to in paragraph 5 and the Chair of the joint
working group.
Article 19
Quorum and opinions of the Committee
1. The quorum necessary for a meeting is achieved when at least 60 percent of all members
having the right to vote are present or represented by a proxy at the meeting at the time
of the agenda point in question.
2. Members having declared a conflic t of interest regarding the relevant agenda point shall
not be regarded as a part of the quorum for the purposes described under paragraph 1
and shall not participate in voting on that agenda point. A member having declared a
conflict of interest regarding an agenda point shall not give a proxy to another member
for that agenda point but may be replaced by their alternate member in the vote.
3. If the quorum is not achieved the Chair may decide to launch a written procedure in
accordance with Article 20.
4. When preparing an opinion, the Committee shall use its best endeavours to reach a
consensus. If consensus cannot be reached, the opinion adopted by the Committee shall
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
9 (10)
consist of the position of the simple majority of the present members having the right to
vote, including their grounds. Members having minority position(s) shall provide them to
the Committee in writing within seven calendar days of the adoption of the opinion, clearly
stating their grounds. The provision of minority position(s) shall be recorded in the
minutes and published.
5. Unless these Rules of Procedure specify otherwise, decisions on any procedural issues
need to be supported by a simple majority of all members having the right to vote.
Article 20
Written procedure
1. The Committee can adopt opinions and take decisions by written procedure. To this end,
the Chair of the Committee shall send the members the draft document(s) on which their
opinion is sought and indicate the response period.
2. The response period shall normally not be shorter than 15 calendar days.
3. Without prejudice to paragraph 4, any member who does not comment within the
response period is considered to have given their tacit agreement to the document. A
document is agreed by consensus following the tacit or express agreement of all members
having the right to vote.
4. When opinions are being adopted, at least 60 percent of the members having the right
to vote have to respond for the written procedure to be regarded as valid.
5. Members having minority position(s) shall provide them to the Secretariat in writing
within seven calendar days of the completion of the written procedure, clearly stating
their grounds. The provision of minority position(s) shall be recorded in the minutes and
be recorded in the written procedure report.
6. If major and justified objections are submitted to the Secretariat, or under other
exceptional circumstances, the Chair shall decide whether the written procedure shall be
suspended or terminated, in whole or in part. If the written procedure is terminated, the
adoption of the opinion or t he agreement of the decision shall be postponed to the next
meeting of the Committee.
7. The Secretariat shall inform the Committee of the outcome of the written procedure and
present the written procedure report, including any opinion or decision, at its ne xt
meeting.
Article 21
Reimbursement
The Agency shall reimburse members of the Committee and, where appropriate, other
participants invited to attend meetings of the Committee in accordance with the applicable
rules adopted by the ECHA Management Board on the reimbursement of travel and other
expenses.
Article 22
General provisions
1. These Rules of Procedure or any amendment to them shall apply from the date they have
been approved by the ECHA Management Board.
2. The decision to amend these Rules of Procedure shall be taken by a two thirds majorit y
of all members having the right to vote. Amendment of the Rules of Procedure shall be
approved by the ECHA Management Board.
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
10 (10)
Annex 1
Links to the Declarations
Declaration of interests and commitment
Declaration of confidentiality
A nnankatu 1 8, P.O . Box 400, FI-00121 Helsinki, Finland | Tel. +3 58 9 686180 | Fax +3 58 9 6 8618210 | echa.europa.eu
1(4)
ECHA
EUROPEAN CHEMICALS AGENCY Helsinki, ? {. 0'1. 20lg
D(2019)0109
EvdP/tk
To: Permanent Representations of the EU member States and EEA Countries
Subject: Renewal of membership of the ECHA Biocidal Products Committee
Dear Sir/Madam,
The Biocidal Products Committee (BPC), which is an integral part of the European Chemicals
Agency (ECHA), was established by the Biocidal Products Regulation (BPR - Regulation (EU)
No 528/2012). The BPC is responsible for preparing the opinion of the Agency in relation to
the tasks specified for biocidal products and their active substances.
Article 75(2) of the BPR states that each Member State shall be entitled to appoint one
member and one alternate member of the BPC. According to Article 75(4) the members are
appointed for a three-year term starting on the date of the first meeting of the Committee
and the appointment is renewable. The term of office of the currently appointed members
and alternates of the BPC is due to expire in April 2OI9.
On behalf of ECHA, I would therefore like to cordially invite you to either renew the
appointment of the current BPC member and alternate member (where appointed) or to
appoint a new member andlor alternate.
Please submit your communication by 31 March 2019 to the BPC functional mailbox:
[email protected] together with the following information:
a In the case of renewal of appointment of the current member and/or
alternate member:
. Communication from your Permanent Representation/Mission to the EU (letter
or email) indicating the intention to renew the appointment(s) as either
member or alternate member;
. Updated declaration of interest (Annex 1);
. Updated expertise grid and CV (Annexes 3 and 4), only if relevant changes
appear since previous submissions of these documents.
a In the case of appointment of new member and/or alternate member:
. Communication from your Permanent Representation/Mission to the EU (letter
or email) indicating your appointment(s) as either member or alternate;
. Completed declarations of interest and confidentiality (Annexes 1 and 2). For
guidance on completing the declarations of interest please see the Annex 6 and
the ECHA procedure on managing potential conflicts of interest (Annex 7);
. Fully completed expertise grid using the template in Annex 3;
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland I Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
2 (4)
Completed brief CV using the template in Annex 4;
Completed Europass CV for the member and alternate member using the
template attached in Annex 5.
ECHA will process any personal data it receives according to Regulation (EC) No 4512001 on
the protection of individuals with regard to the processing of personal data by the EU
institutions and bodies.
BPC members and their role
The members of the BPC are expected to be able to work both during and between meetings
of the BPC. The BPC meets approximately five times per year. The workload of the BPC is
high and covers both biocidal products and their active substances. The opinions adopted by
the BPC shall be in line with the requirements of the BPR but also consistent with the
independence, integrity and scientific credibility of the Agency.
The work of the BPC is regulated by the Rules of Procedure (see Annex B) which specify
many aspects of the Committee's operations, for example procedures for delegating certain
tasks to working groups and use of written procedures.
The work of the BPC is of a dual nature, regulatory and scientific, and the members are
expected to have expertise in both these areas. Specifically, members should have a
biocides regulatory background but also expertise in the relevant scientific and technical
fields identified in Annex 3.
More information on the Committee and its work is available on the dedicated page of the
ECHA website: https://echa.eurooa.eu/about-us/who-we-are/biocidal-products-committee,
General conditions and independence of members
As one element to safeguard the independence, integrity and credibility of the ECHA bodies,
ECHA has adopted a procedure on the prevention and management of potential conflicts of
interest (see Annex 7, mentioned also above). It ensures that a balance is taken between
getting the right expertise to guarantee high quality decision and opinion making, and at the
same time avoiding conflicting interests influencing or seen to be influencing the decision-
making process.
Annankatu 18, P.O. Box 400, FI-00121 Helsinki. Finland I Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
3 (4)
As the appointing authorities, Member States are kindly invited to respect the ECHA policy
on managing potential conflicts of interest and to adhere to the following guidelines for
eligibilityl when appointing the members of the BPC:
Candidates being currently employed by (in a position of relevant importance), or
holding a position in a governing body (whether paid or unpaid) of a commercial
enterprise with an interest in the field of activity of the Agency should not be
appointed. Appointed members should resign from the ECHA body before they enter
into service in any such enterprise;
a Candidates being an active member of, or employed by (in a position of relevant
importance), an association or other body (except a body established under public
law of a Member State serving a public interest) which can be considered as an
interest group with an interest in the field of chemicals management should not be
appointed. Appointed members shall resign from the ECHA body before they enter
into service in any such association;
Candidates who personally have contractual obligations with a commercial entity
or interest group with an interest in the field of activity of the Agency after having
been appointed as members, should (a) withdraw from current contracts and (b)
refrain from entering into any new contracts with such commercial entities or
organisations;
a Candidates who currently hold significant investments in a commercial entity
manufacturing, importing, supplying or placing on the market substances or
mixtures subject to the authority of the Agency, including holding of stocks and
shares, stock options, equity, bonds, partnership interest in the capital of such
undertaking, one of its subsidiaries or a company in the capital of which it has
a holding2 or entitling to substantial voting rights3 in such commercial entity, shall
not be appointed. This is without prejudice to financial interests held through an
investment fund, pension fund and/or interests in non-nominal unit trusts or
similar arrangements, provided that these investments are broadly diversified and
the candidate has no influence on their financial management;
a Candidates who were employed by (in a position of relevant importance), or held a
position in a governing body (whether paid or unpaid) of a commercial enterprise
with an interest in the field of activity of the Agency within the past two years should
not be appointed when the expert has a potential conflict of interest of a general
nature that would potentially lead to multiple exclusions of the individual from the
meetings of the ECHA body or from rapporteurship. The same applies to candidates
who were within the past two years active member of, or employed by (in a position
of relevant importance), an association or other body (except a body established
under public law of a Member State serving a public interest) which can be
considered as an interest group with an interest in the field of chemicals
management.
I Adopted by the ECHA Management Board on 27 September 2OI3 (MB/45/2OL3 final):
http://echa.europa.euldocuments/10162/ 13555/final_mb_45_2013_eligibility_crit_g u id_en. pdf
2 An indicative
amount is ca. 100.000,- EUR per commercial entity
3 An indicative proportion is
ca. 20 Vo voting rights.
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland I Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
4 (4)
Publication of names, qualifications and declarations
Please note that, according to Article 75(4) of the BPR, the membership of the BPC and the
professional qualifications (the brief CV, Annex 4) of the members shall be made public,
Moreover, in accordance with the ECHA value of transparency, the annual declarations of
interest are published. If individual members believe such publication could place them at
risk, they may request by a separate letter addressed to the Executive Director to be added
to the response that their names are not made public; the Executive Director shall decide
whether to agree to such requests.
If you have any questions concerning the appointments, please contact
Mr Erik van de Plassche, Chairman of the Biocidal Products Committee, by email:
[email protected].
Yours sincerel
Bj n
r
cc Contact points from Competent Authorities for the implementation of Reg (EU)
No 528/20L2
BPC members
Martinus Nagtzaam, European Commission, DG SANTE
Leena Yla-Mononen, Head of Unit, ECHA ND1
Erik van de Plassche, Chairman of the BPC, ECHA
Secretariat of the ECHA Management Board
Encls.
Annex 1 ECHA Declaration of interest
Annex 2 ECHA Declaration of confidentiality
Annex 3 Expertise grid template
Annex 4 Brief CV template
Annex 5 Europass CV template
Annex 6 ECHA Guidance for filling in the declaration of interest
Annex 7 ECHA Procedure on preventing and managing potential conflicts of interest
Annex B Rules of procedure of the Biocidal Products Committee
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland I Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
Saatja: Tiiu Noobel <
[email protected]>
Saadetud: 29.01.2019 12:28
Adressaat: SM Info <
[email protected]>; <
[email protected]>; Gerlin Kallas
<
[email protected]>; Elen Ohov <
[email protected]>
Koopia: <
[email protected]>; <
[email protected]>
Teema: FW: Renewal of membership of the ECHA Biocidal Products Committee - Nominations
by 31 March 2019
Manused: image001.png; image002.png; image003.png; image004.png; D(2019)0109_Renewal
of membership of the BPC.pdf; Annex 1_Declaration of interest.docx; Annex 2_Declaration of
confidentiality.docx; Annex 3_BPC expertise grid.xls; Annex 4_Brief CV template.doc; Annex
5_Europass CV Template_EN.doc; Annex 6_Guidance on completing the DoI.pdf; Annex
7_Policy on CoI management_MB 04_2014.pdf; Annex 8_Rules of Procedure.pdf; List of BPC
Members and alternates.pdf
Tere
Edastan Euroopa Kemikaaliameti kirja, mis on registreeritud meie dokumendiregistris nr 14-4/163,
28.01.2019, all.
Nimetamise tähtaeg on 31.03.2019 ja käib EV alaline esindus EL juures kaudu.
Heade soovidega
Tiiu Noobel
Sekretär
Eesti alaline esindus Euroopa Liidu juures
Rue Guimard 11/13, 1040 Brüssel
Tel: + 32 2227 4337,
[email protected]
www.eu.estemb.be
From: ECHA Committee Biocidal Products <
[email protected]>
Sent: esmaspäev, 28. jaanuar 2019 13:18
To:
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; Esindus EL juures üldaadress
<
[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]
Cc:
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; barbara.jaworska-
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; gp-
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]
saude.pt;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; NAGTZAAM Martinus
<
[email protected]>; YLA-MONONEN Leena <Leena.YLA-
[email protected]>; VAN DE PLASSCHE Erik <
[email protected]>; ECHA
Management Board <
[email protected]>; ECHA Committee Biocidal Products
<
[email protected]>
Subject: Renewal of membership of the ECHA Biocidal Products Committee - Nominations by 31 March
2019
To the attention of the Relevant Permanent Representations of the EU Member States and EEA
Countries
Dear Sir/Madam,
Please find attached a letter from the Executive Director of the European Chemicals Agency (ECHA), Mr
Bjorn Hansen, together with annexes.
For your convenience please also find attached a list with the current members and alternate members
of the ECHA Biocidal Products Committee.
Please note that a paper copy will not follow.
Kind regards,
Terhi Kuronen
On behalf of the BPC Secretariat
Terhi Kuronen
BPC Secretariat
Biocidal Active Substances Unit
European Chemicals Agency
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland
Tel. +358 9 6861 8242
[email protected]
http://echa.europa.eu/
The above represents the opinion of the author and is not an official position of the European Chemicals
Agency. This email, including any files attached to it, is intended for the use of the individual to whom it
is addressed. If you have received this message in error, please notify the author as soon as possible and
delete the message.
1(5)
Biocidal Products Committee of the European Chemicals Agency
List of BPC members
MS Member Organisation
Federal Ministry of Agriculture, Forestry, Environment and
JOHN Nina
Water Management
AT
Alternate: Federal Ministry of Agriculture, Forestry, Environment and
PÜRGY Reinhild Water Management
VAN BERLO Boris Federal Public Service Health, Food Chain Safety and
Environment (DG5-Environment)
BE
Alternate: Federal Public Service Health, Food Chain Safety and
AZDAD Karima Environment (DG5-Environment)
RUSCONI Manuel Federal Office of Public Health FOPH, Consumer Protection
Directorate
CH
Alternate: State Secretariat for Economic Affairs SECO, Chemicals and
PYTHON François Occupational Health Section
GAVRIEL Alexandros Ministry of Agriculture
CY
Alternate: Ministry of Agriculture
HADJIGEORGIOU Andreas
VACEK Tomáš Ministry of Health of the Czech Republic
CZ
Alternate:
National Institute for Public Health
MIKOLÃS Jan
2(5)
Federal Institute for Occupational Safety and Health
JÄGER Stefanie
Federal Office for Chemicals (BAuA) /Authorisation of Biocides
DE
Alternate: Federal Institute for Occupational Safety and Health
WEINHEIMER VIOLA Federal Office for Chemicals (BAuA) /Authorisation of Biocides
Environmental Protection Agency
GREGERSEN Nina Falk
Ministry of Environment and Food of Denmark
DK
Alternate: Environmental Protection Agency
CORDUA Birgitte Skou Ministry of Environment and Food of Denmark
Department of Chemicals Safety, Health Board
MERISTE Anu
EE
Alternate:
Department of Chemicals Safety, Health Board
ILMARINEN Kaja
Greek Ministry of Rural Development and Food, Directorate of
VAGIAS Vasileios
Plant Produce, Department of pesticides
EL
Alternate: Greek Ministry Rural Development and Food, Department of
Biocides, Directorate of Plant Produce Protection
GKLIPATHI Dimitra
Ministerio de Sanidad, Servicios Sociales e Igualdad
GONZALEZ MARQUEZ
Maria Luisa
ES
Alternate : Ministerio de Sanidad, Servicios Sociales e Igualdad
CABALLO Covadonga
Finnish Safety and Chemicals Agency (Tukes)
KOIVISTO Sanna
FI
Alternate: Finnish Safety and Chemicals Agency (Tukes)
TUUSA Tiina
3(5)
Anses - French agency for food, environment and
CHÉZEAU Aurélie occupational health safety, Regulated Products Directorate
FR
Alternate: Anses - French agency for food, environment and
occupational health safety, Regulated Products Directorate
COLLET Romy
VRHOVAC FILIPOVIC
Ministry of Health, Department for Chemicals and Biocidal
Ivana Products
HR
Alternate: Institute for Medical Research and Occupational Health
TURK Rajka
SZÁNTÓ Emese Hungarian Biocide Competent Authority, Office of the Chief
Medical Officer of State
HU
Alternate: Hungarian Biocide Competent Authority, Office of the Chief
SZENTGYÖRGYI Tímea Medical Officer
BROWN Finbar Pesticide Control Division, Department of Agriculture, Food
and the Marine
IE
Alternate: Pesticide Registration Division, Department of Agriculture,
CARBERRY Stephen Food and the Marine
RUBBIANI Maristella
Chemical Safety Center - Istituto Superiore di Sanità - ISS
IT
Alternate:
CRESTI Raffaella Istituto Superiore di Sanità – ISS
Administration de l’Environnement
ZIGRAND Jeff
LU
Alternate: Administration de l’Environnement
ENSCH Svenja
4(5)
Latvian Environment, Geology and Meteorology Centre
BROVKINA Julija
LV Department of Information Analysis
Chemicals and Hazardous Waste Division
BORG GALEA Joanne Malta Competition and Consumer Affairs Authority
MT
Alternate: Malta Competition and Consumer Affairs Authority
MALLIA Lothar Paul
Dutch Board for the Authorisation of Plant Protection Products
LANS Martine and Biocides (Ctgb)
NL
Alternate: Dutch Board for the Authorisation of Plant Protection Products
KALKERS Lucas and Biocides (Ctgb)
Norwegian Environment Agency, Section for Biocides and
RANDALL Marit
Declaration of Chemicals
NO
Alternate: Norwegian Environment Agency, Section for Biocides and
GAUSTAD Astrid Declaration of Chemicals
HADAM Anna Office for Registration of Medicinal Products, Medical Devices
and Biocidal Products
PL
Alternate:
Office for Registration of Medicinal Products, Medical Devices
HUSZAŁ Sylwester
and Biocidal Products
Divisão de Saúde Ambiental e Ocupacional, Direção Geral da
BORGES Teresa Saúde
PT
Alternate:
MARTINS DE ALMEIDA
Inês Direção Geral de Alimentação e Veterinária
5(5)
DRAGOIU Simona National Institute of Public Health
RO
Swedish Chemicals Agency (KemI)
HAHLBECK Edda
SE
Alternate: Swedish Chemicals Agency (KemI)
IAKOVIDOU Mary
Ministry of Health, Chemicals Office of the Republic of
ČEBAŠEK Petra Slovenia
SI
Alternate:
Ministry of Health
TERNIFI Vesna
Centre for chemical substances and preparations
MIKOLASKOVA Denisa Ministry of Economy of the Slovak Republic
SK
Centre for chemical substances and preparations
Alternate: Ministry of Economy of the Slovak Republic
CHMELÍKOVÁ Jana
Health and Safety Executive
COSTIGAN Michael
UK
Alternate:
GREGG Nicola Health and Safety Executive
o0o
Fields and levels of expertise relevant to the work of the Biocidal Products Committee
Members
Name of the member:
Member State appointing the member:
BPC members should have a good experience of the regulatory context in which they are working but also a sound scientific and
technical understanding.
Members or alternates are asked to fill in the grid below by entering a "X" in the relevant boxes according to the person's areas of
expertise and available in-depth expertise in their national institutions or authorities. This information will be by the ECHA Secretariat to
derive an overview of the collective expertise of the BPC members to identify any potential gaps. Please therefore return the completed
grid in electronic format.
I Regulatory Mark "X" where applicable
In-depth Some general Access to in-depth
Field of expertise/experience Knowledgeable
expertise knowledge expertise at national level
Knowledge of national, EU or international policies on biocides
Knowledge of the detailed requirements of Biocidal Products
Regulation and its policy objectives
Knowledge of Biocidal Products Directive (98/8/EC)
Experience in National Authorisation
Experience of the Review Programme for Biocides
Expertise in certain biocidal product types*
Knowledge of relevant regulatory guidance
II Hazard and risk assessment
In-depth Some general Access to in-depth
Field of expertise/experience Knowledgeable
expertise knowledge expertise at national level
(1) General
Substance identification and analytical methods
Assessment of physico-chemical properties and physical hazards
Efficacy
Resistance
In-depth Some general Access to in-depth
Field of expertise/experience Knowledgeable
expertise knowledge expertise at national level
(2) Human Health
Toxicology
Human exposure assessment
Human health risk assessment
Mitigation measures
In-depth Some general Access to in-depth
Field of expertise/experience Knowledgeable
expertise knowledge expertise at national level
(3) Environment
Ecotoxicology
Exposure assessment
Environmental risk assessment
Mitigation measures
Page 1 of 1
Europass Insert photograph. Remove heading if not relevant (see instructions)
Curriculum Vitae
Personal information
First name(s) / Surname(s) First name(s) Surname(s) (remove if not relevant, see instructions)
Address(es) House number, street name, postcode, city, country (remove if not relevant, see instructions)
Telephone(s) (remove if not relevant, see Mobile: (remove if not relevant, see
instructions) instructions)
Fax(es) (remove if not relevant, see instructions)
E-mail (remove if not relevant, see instructions)
Nationality (remove if not relevant, see instructions)
Date of birth (remove if not relevant, see instructions)
Gender (remove if not relevant, see instructions)
Desired employment / (remove if not relevant, see instructions)
Occupational field
Work experience
Dates Add separate entries for each relevant post occupied, starting from the most recent. (remove if not
relevant, see instructions)
Occupation or position held
Main activities and responsibilities
Name and address of employer
Type of business or sector
Education and training
Dates Add separate entries for each relevant course you have completed, starting from the most recent.
(remove if not relevant, see instructions)
Title of qualification awarded
Principal subjects/occupational skills
covered
Name and type of organisation
providing education and training
Level in national or international (remove if not relevant, see instructions)
classification
Personal skills and
competences
Mother tongue(s) Specify mother tongue (if relevant add other mother tongue(s), see instructions)
Other language(s)
Self-assessment Understanding Speaking Writing
European level (*) Listening Reading Spoken interaction Spoken production
Language
Language
Page 1/2 - Curriculum vitae of For more information on Europass go to http://europass.cedefop.europa.eu
Surname(s) First name(s) © European Union, 2004-2010 24082010
(*) Common European Framework of Reference for Languages
Social skills and competences Replace this text by a description of these competences and indicate where they were acquired.
(Remove if not relevant, see instructions)
Organisational skills and Replace this text by a description of these competences and indicate where they were acquired.
competences (Remove if not relevant, see instructions)
Technical skills and competences Replace this text by a description of these competences and indicate where they were acquired.
(Remove if not relevant, see instructions)
Computer skills and competences Replace this text by a description of these competences and indicate where they were acquired.
(Remove if not relevant, see instructions)
Artistic skills and competences Replace this text by a description of these competences and indicate where they were acquired.
(Remove if not relevant, see instructions)
Other skills and competences Replace this text by a description of these competences and indicate where they were acquired.
(Remove if not relevant, see instructions)
Driving licence State here whether you hold a driving licence and if so for which categories of vehicle. (Remove if not
relevant, see instructions)
Additional information Include here any other information that may be relevant, for example contact persons, references, etc.
(Remove heading if not relevant, see instructions)
Annexes List any items attached. (Remove heading if not relevant, see instructions)
Page 2/2 - Curriculum vitae of For more information on Europass go to http://europass.cedefop.europa.eu
Surname(s) First name(s) © European Union, 2004-2010 24082010